Biotech developing antibodies for severe autoimmune/allergic diseases and cancer.
Industry: Health Care
First Day Return: +51.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/11/2013 |
Offer Price | $5.50 |
Price Range $5.50 - $5.50 | |
Offer Shares (mm) | 12.7 |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 12/02/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Monrovia, CA, United States |
Founded | 1997 |
Employees at IPO | 31 |
Website www.xencor.com |